ENCOURAGE: Evaluating Community Peer Advisors and Diabetes Outcomes in Rural Alabama
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus
- Sponsor
- Weill Medical College of Cornell University
- Enrollment
- 424
- Primary Endpoint
- LDL cholesterol
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
It is unclear whether peer coaching is effective in minority populations living with diabetes in hard-to-reach, under resourced areas such as the rural South. We examined the effect of an innovative peer coaching intervention plus brief education vs. brief education alone on diabetes outcomes.
Detailed Description
The purpose of this project was to provide robust evidence on the effectiveness of a peer support intervention in improving diabetes outcomes by conducting a group-randomized, controlled implementation trial of a volunteer peer support intervention. The study had three specific aims: Aim 1. In Phase I (months 0-8), to perform a qualitative needs assessment with peer advisors and health care providers to inform peer advisor roles and responsibilities (i.e., the intervention) and peer advisor recruitment strategies, curriculum and training; and patient recruitment plans. Aim 2. Also in Phase I, to pilot our collaboratively developed intervention and, based on pilot test results, to recruit and train peer advisors for the intervention, and begin patient recruitment. Aim 3. In Phase II (months 9-32), conduct the group randomized implementation trial and evaluate it using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework.
Investigators
Monika M. Safford
Professor
Weill Medical College of Cornell University
Eligibility Criteria
Inclusion Criteria
- •19 or older in age, diagnosed with diabetes, under the care of a doctor
Exclusion Criteria
- •not community dwelling, less than 19 years old, pregnant, end-stage medical conditions with limited life expectancy, no access to telephone, does not speak english
Outcomes
Primary Outcomes
LDL cholesterol
Time Frame: Change in LDL cholesterol in 12 month
measured using finger stick, spectrophotometer to measure LDL cholesterol
depressive symptoms
Time Frame: change in depressive symptoms at 12 months
self-report using Patient Health Questionnaire 8 (PHQ8)
Glycated hemoglobin (A1c)
Time Frame: Change in A1c in 12 months
fingerstick, point-of-care a1c test
Blood pressure
Time Frame: Change in blood pressure measure in 12 months
Measured using digital automated blood pressure monitor
diabetes self-care behaviors questionnaire
Time Frame: Change in diabetes self-care behaviors at 12 months
aspects of diabetes self-management such as taking medications as directed, self-report of exercise, and eating behaviors
patient activation
Time Frame: change in patient activation in 12 months
self-report using the 13 item Patient Activation Measure (PAM13)
quality of life
Time Frame: Change in quality of life measures at 12 months
self-report using Short form-1 (SF1), and Euroquol (EQ-5D)
Secondary Outcomes
- body mass index(change in BMI in 12 months)
- composite measure of healthcare utilization(Change in health care utilization in 12 months)
- diabetes knowledge(change in diabetes knowledge in 12 months)
- trust in physicians(change in trust in physicians in 12 months)